Evidence map›Paper›PMID 38063302›Full record

ArticleeLife2023

Homeostasis, injury, and recovery dynamics at multiple scales in a self-organizing mouse intestinal crypt.

Louis Gall, Carrie Duckworth, Ferran Jardi, Lieve Lammens, Aimee Parker, Ambra Bianco, Holly Kimko, David Mark Pritchard, Carmen Pin

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. BioModels' model of the year 2024.Frontiers in systems biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Louis GallClinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.ORCID 0000-0002-1805-2357
Carrie DuckworthInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Ferran JardiPreclinical Sciences and Translational Safety, Janssen, Beerse, Belgium.
Lieve LammensPreclinical Sciences and Translational Safety, Janssen, Beerse, Belgium.
Aimee ParkerGut Microbes and Health Programme, Quadram Institute, Norwich, United Kingdom.
Ambra BiancoClinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, United Kingdom.
Holly KimkoClinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.
David Mark PritchardInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0001-7971-3561
Carmen PinClinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.ORCID 0000-0001-8734-6167
AstraZeneca (Australia) · AUJanssen (Belgium) · BEUniversity of Liverpool · GBAstraZeneca (Brazil) · BRQuadram Institute · GB

Funding

European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative 2 No. 116030European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative 2,No. 116030Horizon 2020 Framework Programme Innovative Medicines Initiative 2 No. 116030Horizon 2020 Framework Programme Innovative Medicines Initiative 2,No. 116030
6 · The paper itself

Abstract

The maintenance of the functional integrity of the intestinal epithelium requires a tight coordination between cell production, migration, and shedding along the crypt-villus axis. Dysregulation of these processes may result in loss of the intestinal barrier and disease. With the aim of generating a more complete and integrated understanding of how the epithelium maintains homeostasis and recovers after injury, we have built a multi-scale agent-based model (ABM) of the mouse intestinal epithelium. We demonstrate that stable, self-organizing behaviour in the crypt emerges from the dynamic interaction of multiple signalling pathways, such as Wnt, Notch, BMP, ZNRF3/RNF43, and YAP-Hippo pathways, which regulate proliferation and differentiation, respond to environmental mechanical cues, form feedback mechanisms, and modulate the dynamics of the cell cycle protein network. The model recapitulates the crypt phenotype reported after persistent stem cell ablation and after the inhibition of the CDK1 cycle protein. Moreover, we simulated 5-fluorouracil (5-FU)-induced toxicity at multiple scales starting from DNA and RNA damage, which disrupts the cell cycle, cell signalling, proliferation, differentiation, and migration and leads to loss of barrier integrity. During recovery, our in silico crypt regenerates its structure in a self-organizing, dynamic fashion driven by dedifferentiation and enhanced by negative feedback loops. Thus, the model enables the simulation of xenobiotic-, in particular chemotherapy-, induced mechanisms of intestinal toxicity and epithelial recovery. Overall, we present a systems model able to simulate the disruption of molecular events and its impact across multiple levels of epithelial organization and demonstrate its application to epithelial research and drug development.

Indexed as

Intestinal MucosaIntestinesAnimalsCell DifferentiationCell ProliferationHomeostasisMice5-FUagent-based modelcomputational biologydrug toxicityintestinal cryptmousestem cellssystems biologysystems models

Identifiers

PMID38063302
PMCPMC10789491
OpenAlexW4389487965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.